CTOs on the Move

Georgia Atkison Snf

www.alliancenursingrehab.com

 
Georgia Atkison Snf is a El Monte, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Alltech

Headquartered in Lexington, Kentucky, Alltech has developed a strong global presence in 128 countries. It also has 31 production facilities strategically located throughout the world.         We are one of the industry leaders in the animal feed industry, but being a leader brings responsibility. This means that we care about the impact we have on the people and places touched by our mission to improve animal health around the world.

Julie Hewett

Julie Hewett is a North Hollywood, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Zeltiq Aesthetics Inc

Zeltiq Aesthetics Inc is a Pleasanton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

The California Poison Control System (CPCS)

The California Poison Control System (CPCS) is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Enterin Inc.

Enterin is pioneering the medical community`s understanding of the link between infections, dysfunction of the enteric nervous system (ENS) of the gut, and the early onset and chronic progression of neurodegenerative disease. We are leveraging years of research to become the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease. Our lead compound, ENT-01 (also known as kenterin), displaces membrane-bound alpha- synuclein (αS) aggregates from nerve cells in the ENS and improves neural signaling between the gut and the brain in preclinical models of Parkinson`s disease. In the gut, this results in improved motility. We are now progressing this drug through clinical trials in an attempt to reverse the constipation of Parkinson`s disease. Our long-term mission is to become the world leader in developing pharmaceutical therapies that repair the gut-brain axis.